These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasoreactivity in pre- and postmenopausal women: evaluation by pharmacodynamic modeling. Ching MI; Sung BH; Forrest A; Wilson MF; Izzo JL J Clin Pharmacol; 1998 Feb; 38(2):151-9. PubMed ID: 9549646 [TBL] [Abstract][Full Text] [Related]
3. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Sudhir K; Elser MD; Jennings GL; Komesaroff PA Hypertension; 1997 Dec; 30(6):1538-43. PubMed ID: 9403579 [TBL] [Abstract][Full Text] [Related]
4. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. Majmudar NG; Robson SC; Ford GA J Clin Endocrinol Metab; 2000 Apr; 85(4):1577-83. PubMed ID: 10770200 [TBL] [Abstract][Full Text] [Related]
5. Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women. Sofowora GG; Singh I; He HB; Wood AJ; Stein CM Clin Auton Res; 2005 Jun; 15(3):193-9. PubMed ID: 15944868 [TBL] [Abstract][Full Text] [Related]
6. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement. Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355 [TBL] [Abstract][Full Text] [Related]
7. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. Mercuro G; Longu G; Zoncu S; Cherchi A Am Heart J; 1999 Apr; 137(4 Pt 1):692-7. PubMed ID: 10097232 [TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Bush DE; Jones CE; Bass KM; Walters GK; Bruza JM; Ouyang P Am J Med; 1998 Jun; 104(6):552-8. PubMed ID: 9674718 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Jhund PS; Dawson N; Davie AP; Sattar N; Norrie J; O'Kane KP; McMurray JJ J Am Coll Cardiol; 2001 Apr; 37(5):1367-73. PubMed ID: 11300448 [TBL] [Abstract][Full Text] [Related]
10. Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes. Manwaring P; Phoon S; Diamond T; Howes LG Maturitas; 2002 Nov; 43(3):157-64. PubMed ID: 12443833 [TBL] [Abstract][Full Text] [Related]
11. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Lindheim SR; Legro RS; Bernstein L; Stanczyk FZ; Vijod MA; Presser SC; Lobo RA Am J Obstet Gynecol; 1992 Dec; 167(6):1831-6. PubMed ID: 1471706 [TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity. Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718 [TBL] [Abstract][Full Text] [Related]
19. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. Lim SC; Caballero AE; Arora S; Smakowski P; Bashoff EM; Brown FM; Logerfo FW; Horton ES; Veves A J Clin Endocrinol Metab; 1999 Nov; 84(11):4159-64. PubMed ID: 10566666 [TBL] [Abstract][Full Text] [Related]
20. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women. Luyer MD; Khosla S; Owen WG; Miller VM J Clin Endocrinol Metab; 2001 Aug; 86(8):3629-34. PubMed ID: 11502788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]